Public spending on immunisation in Poland

With 1.7% of its healthcare budget allocated to prevention and 0.5% to vaccinations, Poland remains a country that invests relatively little in preventive measures. Given the high return on investment in immunisation-through reductions in both direct and indirect costs and in severe outcomes-increased and sustainable public funding for vaccination should be prioritised by healthcare policymakers. Sustainable public investment is crucial to addressing key immunisation challenges: low coverage, delayed introduction of cost-effective vaccines and service quality gaps. Rather than being driven by international expenditure comparisons, this investment should be justified by the evidence-based potential of immunisation to reduce the health and economic burden of vaccine-preventable diseases.